Geron Corp. took a step forward in the production of human embryonic stem (hES) cells, disclosing new technology that would make it possible to grow the cells without using mouse cells. The technique, which allows the propagation of hES cells without the use of mouse embryonic fibroblast (MEF) feeder cells, has implications for the xenobiotic classification of hES production by